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Deafness in pediatric age can adversely impact language acquisition as well as educational and social-emotional
development. Once diagnosed, hearing loss should be rehabilitated early; the goal is to provide the child with
maximum access to the acoustic features of speech within a listening range that is safe and comfortable. In presence
of severe to profound deafness, benefit from auditory amplification cannot be enough to allow a proper language
development. Cochlear implants are partially implantable electronic devices designed to provide profoundly deafened
patients with hearing sensitivity within the speech range. Since their introduction more than 30 years ago, cochlear
implants have improved their performance to the extent that are now considered to be standard of care in the
treatment of children with severe to profound deafness. Over the years patient candidacy has been expanded and
the criteria for implantation continue to evolve within the paediatric population. The minimum age for implantation
has progressively reduced; it has been recognized that implantation at a very early age (12–18 months) provides
children with the best outcomes, taking advantage of sensitive periods of auditory development. Bilateral implantation
offers a better sound localization, as well as a superior ability to understand speech in noisy environments than unilateral
cochlear implant. Deafened children with special clinical situations, including inner ear malformation, cochlear nerve
deficiency, cochlear ossification, and additional disabilities can be successfully treated, even thogh they require
an individualized candidacy evaluation and a complex post-implantation rehabilitation. Benefits from cochlear
implantation include not only better abilities to hear and to develop speech and language skills, but also improved
academic attainment, improved quality of life, and better employment status. Cochlear implants permit deaf people
to hear, but they have a long way to go before their performance being comparable to that of the intact human ear;
researchers are looking for more sophisticated speech processing strategies as well as a more efficient coupling
between the electrodes and the cochlear nerve with the goal of dramatically improving the quality of sound of
the next generation of implants.
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Hearing loss (HL) during the first 3 years of life can
hinder speech and language acquisition with significant
negative consequences on a child’s educational and psy-
chosocial development. HL can be classified as conduct-
ive or sensorineural in nature; conductive hearing loss
(CHL) is related to a disorder of the external and/or
middle ear, which impacts on sound transmission toward
the inner ear. Depending on the etiology of the CHL, the
rehabilitation includes drug therapy, external and/or mid-
dle ear surgery, and hearing aids. Instead, sensorineural* Correspondence: vincenzo.vincenti@unipr.it
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unless otherwise stated.hearing loss (SNHL) affects the cochlea, which transforms
sound vibration into a neural signal, or, the cochlear nerve,
which transmits this signal to the auditory brain. Most
SNHL is sensory and limited to the cochlea rather than
neural [1]. The amount of SNHL is measured in decibels
hearing level (dBHL) and classified in terms of pure tone
average (PTA), the average of hearing thresholds for pure
tone sounds, measured at 500, 1000, and 2000 Hz. Based
on this classification, SNHL is ranked as mild (PTA be-
tween 21 and 40 dBHL), moderate (PTA between 41 and
70 dBHL), severe (PTA between 71 and 90 dBHL), and
profound (PTA >90 dBHL). The treatment of SNHL varies
depending on its severity and whether it affects one ear or
both. Mild to severe SNHL can be successfully rehabili-
tated by means of hearing aids; however, in presence ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Cochlear implant (external part). 1: microphone;
2: speech processor; 3: external antenna; 4: magnet.
Figure 2 Cochlear implant (internal part).
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louder, may be not enough to properly understand and de-
velop speech. In fact, SNHL cause sounds to become dis-
torted and amplification through hearing aids makes them
louder but not necessarily clearer. Under these circum-
stances, the best way for hearing and learning proper
speech is represented by a cochlear implant (CI); this is an
electronic device that bypasses the cochlea by means of an
electrode array stimulating directly the cochlear nerve,
thereby transmitting an electrical signal to the auditory
cortex. Since their introduction more than 30 years ago,
CIs have improved their performance to the extent that are
now considered to be standard of care in the treatment of
children with severe to profound SNHL loss [2]. Because
of the incessant progress in the field of CIs, criteria for im-
plantation continue to evolve within the pediatric popula-
tion; at the same time, patient candidacy has broadened
and changed over the years. The aim of this review was to
take stock of the current indications, applications and out-
comes in pediatric cochlear implantation.
Background
SNHL is the most common congenital sensory deficit,
with an incidence of one to three per 1000 live births;
this incidence mounts up to 4-5% in neonates with risk
factors for SNHL [3]. Genetic causes account for ap-
proximately 50% to 60% of pediatric SNHL, while 15%
to 40% is due to an acquired cause, such as infections,
ototoxic drugs, anoxia, low birth weight, hyperbilirubi-
nemia, traumas, metabolic and autoimmune diseases
[4-6]. A specific cause is still not identifiable in 15% to
30% of childhood SNHL [7].
In normal-hearing subjects, the sensory hair cells
within the cochlea transform sound vibration into a
neural signal; the latter is then transmitted via the coch-
lear nerve to the auditory cortex. CIs work by substitut-
ing these cells with electrodes that stimulate electrically
the auditory nerve fibers. A CI has an external component,
worn behind the ear just as a hearing aid, and an internal
component, surgically embedded in the mastoid.
The external part (Figure 1) consists of a microphone
for obtaining sound, a speech processor that analyzes
and encodes sound into a digital code, and a magnetic
headpiece transmitting the coded signal to the internal
part via a transcutaneous radiofrequency link to the in-
ternal part.
The internal part (Figure 2) contains a receiver-
stimulator (having a size as a pacemaker) that receives
and decodes the data, and in turn sends the decoded sig-
nal to the electrode array. The latter is the core of the
system and consists of a flexible silicone carrier contain-
ing a variable number of electrodes. The electrode array
is surgically inserted into the scala tympani of the coch-
lea and stimulates directly the residual cochlear nervefibers. On the European market, there are four types of
CIs that differ in design, shape and number of electrodes,
strategy of speech processing, accessories. Figure 3 shows
how a cochlear implant works.
Candidacy evaluation, patient selection and surgical notes
Several factors must be considered to establish whether
a child is suitable for implantation; thus, the patient se-
lection is of outstanding importance for a successful
cochlear implantation. A complete evaluation should
comprise a series of tests, including audiologic, medical
and imaging studies, as well as speech and language evalu-
ation; furthermore, patient/family counseling is fundamen-
tal to explain them the potential benefits and to create
realistic expectations.
Figure 3 How a cochlear implant works. The microphone (1) picks
up sound; the speech processor (2) analyzes and transforms sound into
digital information; the magnetic headpiece (3) transmits the coded
signal to the surgically implanted part (4); the intracochlear electrodes
(5) stimulate the cochlear nerve fibers (6).
Table 1 Current contraindications for cochlear implantation
Absolute Relative
Absence of cochlear development Aplasia of the acoustic nerve
Deafness due to lesions of the
central auditory pathway
Medical conditions or developmental
delays that would severely limit
partecipation in aural habilitation
Massive cochlear ossification that
prevents electrode insertion
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criteria for candidacy to cochlear implantation needs to
be verified. Pediatric audiologic evaluation is based on
several subjective and objective hearing tests. Taken to-
gether, these tests aim at accurately identifying the de-
gree of HL across the audiometric frequencies. The
current guidelines indicate that patients until the age of
2 years should have a bilateral profound SNHL (PTA for
500, 1000 and 2000 Hz >90 dBHL), while children older
than 2 years should have a severe to profound SNHL
(PTA for 500, 1000 and 2000 Hz >75 dBHL) [8,9]. Fur-
thermore, cochlear implantation should be performed
after verifying insufficient benefits from appropriate bin-
aural hearing aids and intensive aural rehabilitation. The
preoperative speech and language evaluation is equally
important for the decision-making process, as well as to
monitor the appropriateness of the rehabilitation pro-
gram; auditory performance, speech production and
mode of communication should be assessed by means of
different tests appropriately selected according to hear-
ing impairment, chronological age and cognitive status.
In terms of onset, a hearing loss may be defined as pre-
lingual (the hearing impairment occurred before the ac-
quisition of spoken language skills, that is before the age
of 2 years), postlingual (the hearing impairment oc-
curred after the acquisition of speech and language, that
is after the age of 5 years), or perilingual (the hearing
impairment occurred after acquiring some spoken lan-
guage but before acquisition was complete, that is be-
tween 2 and 5 years).The medical evaluation aims at verifying whether the
child is healthy enough to withstand general anesthesia and
surgical procedure. Furthermore, since the risk of develop-
ing meningitis is higher in children with SNHL (implanted
or not) than those one without SNHL, immunization his-
tory should be confirmed; age-appropriate immunization
should be updated at least 2 weeks before implantation ac-
cording to published recommendations [8].
Preoperative imaging assessment is mandatory to ver-
ify the presence of the minimal requirements for coch-
lear implantation, i.e. a patent cochlea and an intact
cochlear nerve. Imaging is crucial to identify findings
that may complicate or require modifications of the
surgical technique, such as cochleo-vestibular malfor-
mations, middle ear and facial nerve anomalies, and
cochlear obstruction. Finally, the radiological study can
contribute in choosing which ear may be more suitable
for implantation. High resolution computed tomography
(HRCT) provides information regarding the structure of
the bony labyrinth, the number and the patency of the
cochlear turns, the size of the internal auditory canal
(IAC), the position of the facial nerve and the vascular
structures, and the anatomy of the middle ear and mas-
toid. Magnetic resonance imaging (MRI) is useful in con-
firming the presence of the cochlear nerve, as well as in
searching for central auditory pathway abnormalities and
fibrous obliteration of the membranous labyrinth. Often,
both imaging modalities are performed in pediatric can-
didates, but the protocol varies among the different coch-
lear implant centers [8]. A trade off between the need to
cut costs and to avoid unnecessary radiations to children
and a detailed radiological study, may be represented by
performing MRI as initial modality, and reserving HRCT
to children in which cochleovestibular anomalies, coch-
lear obstruction or narrowing of the IAC are identified.
Current contraindications for cochlear implantation are
summarized in Table 1.
Surgery is done under general anesthesia and it is usu-
ally well tolerated. CIs are placed through small skin in-
cision in the retroauricolar region (Figure 4a); a surgical
opening (mastoidectomy) is made in the mastoid to pro-
vide access to the cochlea from behind (Figure 4b). Once
identified the round window, the latter is opened and
the electrode array is inserted into the cochlea. After the
Figure 4 Cochlear implant surgery. a: skin incision; b. mastoidectomy; c: cochlear implant secured in place.
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surgical access (Figure 4c), intraoperative electrophysio-
logical testing is performed to verify the correct func-
tioning of the device and to record the neural responses
to the electrical stimuli. In standard cases, the procedure
takes about 2 hours; children are generally discharged
from hospital within 2–3 days. Cochlear implantation
has a low rate (about 10%) of complications; major com-
plications are rare, accounting for only 20 to 30% of all
complications on average [8], and include facial nerve
injury (0.39%), perilymphatic gusher/cerebrospinal fluid
fistula (0.25%), and meningitis (0.11%). The most fre-
quent complications are temporary taste disturbance,
wound infections, and device failure. The activation of
the implant is usually done 2–4 weeks after surgery,
when healing is complete, and consists in setting the
sound levels presented to each electrode within the
cochlea. During the first year after activation, the
cochlear implant is periodically tuned according to
the child responses in order to maintain optimal stimula-
tion levels.
Discussion
Modern multichannel CIs were introduced in the late
1970s; only post-lingually deafened adults were consid-
ered candidates for implantation. As consequence of the
excellent results achieved in adults and after the safety
of the device had been confirmed, in 1990 FDA ap-
proved the use of CIs in congenitally deafened children;
since then, the candidacy criteria in pediatric age have
changed and expanded over the years.
As for the ideal age for implantation in presence of
congenital deafness, there has been a growing trend to
decrease it. The lack of auditory information from the
environment during early childhood impedes the normal
development of the auditory system, and interferes with
the acquisition of language skills. In fact, there is a win-
dow of time in the first 3 years of life (the “sensitive
period”), during which the child’s brain is very plastic
and has the ability to develop new neural pathways in
response to auditory stimuli [10]. Behind this period, the
auditory cortex can no longer be recruited by auditoryinput because the intact senses take over the audi-
tory neural network through a process of cross-modal
reorganization [11]. The rationale behind early cochlear
implantation is to minimize the consequences related
to sensory deprivation during the sensitive period. Sev-
eral studies have shown that children implanted before
2 years of age perform significantly better than children
implanted at older ages [8,12,13]. In presence of bilateral
profound SNHL and limited benefit from appropriate
binaural hearing aids, the goal is to implant, as soon as
possible, bearing in mind that the inferior limit is also con-
ditioned by surgical and anesthesiological risks [14]. Cur-
rently, the FDA has approved cochlear implantation in
12 months and older children, but some centers are
implanting infants as young as 6 months [13]. Colletti et al.
[15] reported on 12 children implanted at or before the
age of 6 months; four years after implantation, these chil-
dren had receptive and expressive language skills similar
to normal-hearing peers. However, other studies did not
confirm clear evidence of improved outcomes in children
implanted in the first year of life compared with those im-
planted a year later [16]. In addition, a major concern in
performing early implantation for very young infants is
the reliability of the audiologic tests. Children with SNHL
from meningitis deserves special attention because a post-
infectious inflammatory process, the so-called labyrinthitis
ossificans, can lead, in a few months, to a cochlear ob-
struction with fibrous or bony tissue that makes electrode
insertion more challenging or even impossible [14]. For
this reason, in these cases it is often necessary to expedite
surgery.
Recently, cochlear implant candidacy has been ex-
tended also to some children with significant residual
hearing [17]. An example is a bilateral and asymmetric
SNHL, in which significant benefit can derive from coch-
lear implantation in the worse hearing ear in combination
with a hearing aid in the better ear [18]. The combination
of acoustic and electrical stimulation, in the same ear, can
be applied in children with the so-called “ski-slope hearing
loss”, where low frequencies up to 1000 Hz are well-
preserved, while a severe to profound hearing loss is
present in the frequencies over 1000 Hz [12]. Under these
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fication of the high frequencies necessary for oral commu-
nication. Specially manufactured short electrodes or
conventional electrodes inserted only in the high frequency
area of the cochlea by means of “soft surgery” can allow
preservation of residual hearing; this situation offers the
possibility to transmit the high frequency information
through an electrical stimulation, and the low frequency
information through an acoustic stimulation [19].
Inner ear malformations (IEMs) (Table 2) are present
in approximately 20% of children with congenital SNHL
[20,21]. Initially, IEMs were considered as a contraindi-
cation to cochlear implantation, mainly because histo-
pathologic reports showed decreased and irregularly
distributed neural tissue in the malformed cochleas [22].
Moreover, in presence of temporal bone anomalies, the
surgeon may be confronted with several challenging
problems, including cerebrospinal fluid gusher, facial
nerve injury, and electrode misplacement into the IAC
[12]. The increased experience in the surgical techniques
[23,24], as well as the progressive advancement of coch-
lear implant technology, has led to more children with
IEMs to be considered as candidates. The review of the
literature showed that functional outcomes are inversely
correlated with the severity of malformation [12,23]. Mild
anomalies, such as enlarged vestibular aqueduct or in-
complete partition, are usually associated with outcomes
similar to those of children without malformations. Se-
vere abnormalities, such as common cavity, cochlear hy-
poplasia, stenotic IAC, and cochlear nerve deficiency,
also benefit from implantation, but with poorer perform-
ance [25,26]. Other important prognostic factors include
progressive SNHL, duration of implant use and the pres-
ence of additional handicaps [27].
More than 30% of children with SNHL have additional
disabilities, such as developmental delay, autism and
attention deficit hyperactive disorders, cerebral palsy,
visual impairment, mental retardation [28]. AlthoughTable 2 Cochleo-vestibular malformations as classified by
Sennaroglu and Saatci [20]
Malformation Characteristics
Labyrinthine aplasia Complete absence of cochlea and vestibule
Cochlear aplasia Cochlea absent, vestibule present
Common cavity Cochlea and vestibule are represented by a
single, undifferentiated cystic cavity
Incomplete partition type 1 Cystic-appearing cochlea lacking entire
modiolus and cribriform area; large cystic
vestibule
Cochlear hypoplasia Cochlea and vestibule smaller than normal
Incomplete partition type 2 Cochlea consists of 1.5 turns (normally it
has 2.5 turns); middle and apical turns
coalesce to form a cystic apexcertain such patients develop speech perception and
language skills, additional disabilities are usually associ-
ated with poor performance in terms of development of
oral communication [29-31]. However, in this specific
population of patients, parameters of success are hard to
define. Families of children with disabilities often per-
ceive significant benefits from cochlear implantation in
terms of awareness of the environment, improved inter-
actions with peers, vocalization and developing speaking
skills [32,33]. Based on the possibility to improve their
quality of life, actually many centers offer cochlear im-
plantation to children with additional disabilities, once
verified that parental expectations are appropriate and
realistic. Anyway, these children require complex and in-
dividualized therapy to maximize benefit from cochlear
implantation [28].
Binaural hearing is fundamental in the localization of
the sound as well as in listening in noisy environments.
Children with unilateral cochlear implant and little or
no usable hearing in the non-implanted ear show defi-
ciency in both tasks because of the lack of binaural hear-
ing [12]. In order to improve performance, binaural
cochlear implantation has been introduced over the past
decade. Bilateral cochlear implantation may be per-
formed during either a single (simultaneous) or two dif-
ferent (sequential) interventions. Both techniques have
been shown to be effective; however, if a sequential strat-
egy is chosen, the inter-stage interval has to be prefera-
bly comprised between 6 and 12 months to maximize
the performance with the second implant [34]. It has
been recognized that children with bilateral CIs have im-
proved speech understanding in noise and better abilities
to localize sound, both in quiet and in noise, than chil-
dren with one implant only [2,35]. In addition, bilaterally
implanted patients develop complex expressive and re-
ceptive spoken language, and use significantly more au-
dition and vocalization in communication in the early
postimplantation period than their unilaterally implanted
peers [36-38]. Finally, bilateral cochlear implantation
promotes the development of the central auditory sys-
tem through bilateral cortical stimulation, ensures that
the better ear is always implanted and provides recipi-
ents to have a backup if one device fails or malfunctions
[39]. Although there are also some disadvantages in
choosing bilateral implantation, including increased time
of surgery or two separate surgeries, increased expenses,
and inability to preserve one ear for newer therapies, nu-
merous authors agree that the pros often outweigh the
cons [14,35,36].
Conclusions
Cochlear implantation is worldwide considered a safe and
highly effective technique in rehabilitating children with se-
vere to profound SNHL. To understand the improvements
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cochlear implant recipients were usually compared with
age-matched deaf children who used high-powered hearing
aids as controls; nowadays, they are compared with age-
matched normal-hearing children. Benefits include not
only better abilities to hear and to develop speech and lan-
guage skills, but also improved academic attainment, im-
proved quality of life, and better employment status. As a
consequence, the society also derives benefit from cochlear
implantation; such rehabilitation technique is costs-saving
by cutting educational costs and restoring the work prod-
uctivity potential. Early intervention and a short duration
of deafness before implantation are associated with the best
language acquisition results, taking advantage of sensitive
periods of auditory development. When clinically appropri-
ate, bilateral cochlear implantation should be considered
for the advantages it offers in terms of sound localization
and speech understanding in noisy environments. Ad-
vancement of technology, improvement of surgical tech-
niques, as well as increased understanding of auditory
system, allowed candidacy criteria for pediatric cochlear
implantation to be expanded; currently, more deaf chil-
dren with various adverse conditions can benefit from
this revolutionary technique. However, it is necessary to
always bear in mind that CIs have their limitations since
these devices allow deaf people to become integrated in
the hearing world but do not restore normal hearing; in
addition, outcomes still vary among patients. It is hoped
that future researches will improve the delivering of the
fine-structure content of the speech signal and respon-
siveness of the brain to electrical stimulation.
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